ClinicalTrials.gg
Sign In

Autoimmune Diseases clinical trials

The registry lists 802 studies for Autoimmune Diseases across more than 10 countries. 271 are recruiting or about to start. 219 of them are mainly about Autoimmune Diseases (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-10. Counting its 41 narrower conditions too, such as Diabetes Mellitus, Type 1: 15,730 studies, 3,333 open.

ClinicalTrials.gov finds 15,606 studies for Autoimmune Diseases. How that becomes 802 here

This page counts the studies the registry files under Autoimmune Diseases, and those it files under no condition that list Autoimmune Diseasesthemselves. Each study its search finds is placed by how the registry filed it and by the conditions it lists. ClinicalTrials.gov counts as of Nov 8, 2026. How condition pages count

  1. 15,606Found by its condition searchIt reads the conditions a study lists and their synonyms, and also titles and keywords.
  2. −14,438Filed under a narrower condition, counted on its own pageDiabetes Mellitus, Type 1 3,509 · Arthritis, Rheumatoid 3,201 · Multiple Sclerosis 3,078 · Lupus Erythematosus, Systemic 956 · Purpura, Thrombocytopenic, Idiopathic 450 · Arthritis, Juvenile 311 · 34 more
  3. −13List Autoimmune Diseases as a condition, but the registry did not file them under itMost often written as “Systemic Autoimmune Diseases” (4), “Raynaud's Disease Secondary to Autoimmune Disease” (1), and “Raynaud's Disease Secondary to Other Autoimmune Disease” (1). The registry filed them under other conditions only, most often Raynaud Disease (2) and Scleroderma, Diffuse (2).
  4. −353Match it another way32 name it in the title, 7 in a keyword, and 314 by a synonym or other text the search reads.
  5. 802The count on this page14 of them list Autoimmune Diseases in their own words; the registry filed them under no condition.

Get an email when these change. Save the Autoimmune Diseases studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
347
Recruiting
194
Not yet recruiting
63
Status unknown
62
Terminated
56
Active, not recruiting
35

Phase

Phase 1
181
Phase 2
178
Phase 3
66
Early Phase 1
50
Phase 4
26

Where

United States
341
China
124
France
96
Germany
75
United Kingdom
73
Spain
66

Who runs them

National Institute of Allergy and Infectious Diseases (NIAID) (22) · GlaxoSmithKline (18) · Assistance Publique - Hôpitaux de Paris (17) · National Heart, Lung, and Blood Institute (NHLBI) (13) · Peking Union Medical College Hospital (11) · Novartis Pharmaceuticals (11) · National Cancer Institute (NCI) (10) · National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) (8)

What is being tested here

Drugs under test in Autoimmune Diseases studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Autologous Anti-CD19 CAR-T Cells CABA-201526
Cyclophosphamide318
Fludarabine304
Belimumab2815
Rituximab2213
Immunoglobulin G2510
Immunoglobulins, Intravenous249
Cyclosporine207
Mivocabtagene autoleucel216
Telitacicept225

Drug classes tested here Antimetabolites 6 open · Alkylating agents 3 open · Corticosteroids 2 open · Calcineurin inhibitors 2 open · GLP-1 receptor agonists 2 open

Coming up

22phase 3 studies under way
81studies finish main data collection within a year7 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Who these studies take

Of the 194 Autoimmune Diseases studies recruiting now, 89 (46%) set no upper age limit and 79 (41%) stop at 75 or younger. 55 (28%) take children under 18. 6 (3%) are for women only and 5 (3%) for men only; 36 (19%) take healthy volunteers.

Recruiting studies that take each age, of 194
AgeWomenMen
1044 (23%)44 (23%)
18179 (92%)177 (91%)
30180 (93%)178 (92%)
40180 (93%)179 (92%)
50179 (92%)180 (93%)
65171 (88%)172 (89%)
75126 (65%)127 (65%)
85107 (55%)107 (55%)

Across all 802 studies, recruiting or not: 46% stop at 75 or younger and 31% at 65; 25% take children; 5% are for women only and 2% for men only; 21% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Autoimmune Diseases studies take

Of 94 phase 1 interventional studies under Autoimmune Diseases, half reached primary completion within 23 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Phase 123 mo9–36 · 94 studies12 mo9–32 · 68 studies—
Phase 255 mo34–100 · 60 studies—76 mo52–114 · 31 studies
Phase 348 mo36–84 · 29 studies——
Interventional, no phase31 mo15–62 · 86 studies—31 mo16–62 · 77 studies
Observational121 mo41–309 · 92 studies—121 mo41–309 · 77 studies

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 13, 2026.

Started recruiting6

Show 1 more

Results posted1

Stopped5

Newly registered5

Studies

Recruiting first, then most recently updated. Showing 50 of 802. Browse all 802 → or search them.